Market Overview:
The global vital organs support systems and medical bionics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of organ failures, technological advancements in medical bionics, and rising demand for minimally invasive surgeries. The vital organs support systems segment is expected to account for the majority share of the global market in 2018. This segment is projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 due to increasing demand for technologically advanced products that can improve patient outcomes.
Product Definition:
The definition of Vital Organs Support Systems and Medical Bionics is a system that helps to support the vital organs in the body, and can also include medical bionics which are devices or implants that help to replace or assist a vital organ. The importance of Vital Organs Support Systems and Medical Bionics is that they help to keep the body functioning properly by supporting the vital organs.
Hospitals:
Hospitals are the primary health systems for most of the population in developed countries. They are also used as a primary care facility for outpatient services and as an emergency department. Hospitals have been evolving continuously to meet patient requirements, to provide better treatment facilities and to reduce costs associated with hospitalization. The advent of technology has led to innovations in medical devices, which is expected to boost market growth over the forecast period.
Ambulatory Surgical Centers:
Ambulatory surgical centers are healthcare facilities that offer a broad range of surgical services in a single setting. They are usually located near the patients' homes and can provide high-quality care at lower costs as compared to hospital settings. Ambulatory surgery centers have been rapidly growing over the past few years and this is mainly due to reduced hospital stays, which in turn reduces medical expenditure for patients as well as insurance providers.
Application Insights:
On the basis of application, the global vital organs support systems and medical bionics market is segmented into vital organs support systems and medical biotechnology. The vital organ support system segment dominated the overall market in terms of revenue share in 2017. This high share can be attributed to a large number of surgical procedures that require transplantation or preservation of a patient¢â‚¬â„¢s life until an organ can be found.
The growing prevalence of chronic diseases such as diabetes, kidney disease, lung disease and liver disease has led to an increase in demand for transplantable organs across the globe. According to data published by WHO, more than 60 million people are living with chronic conditions worldwide; this number is expected to reach 80 million by 2030 if urgent action isn¢â‚¬â„¢t taken now against these diseases globally.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure and high adoption rate for advanced technologies are some factors responsible for its large share. Moreover, increasing demand to curb the shortage of organ donors is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure and improving facilities in rural areas as well as urban centers across countries such as India, China, Singapore, Malaysia and Thailand. In addition, growing medical tourism industry due to availability of advanced treatments at affordable costs will also boost this region’s growth prospects over the next eight years.
Growth Factors:
- Increasing incidence of organ failures and the subsequent need for organ transplants is expected to drive the demand for Vital Organs Support Systems and Medical Bionics over the forecast period.
- Technological advancements in medical bionics are anticipated to result in increased adoption of these systems, thereby propelling market growth.
- Growing awareness about benefits offered by Vital Organs Support Systems and Medical Bionics is likely to boost demand over the next few years.
- Rising number of surgical procedures owing to increasing prevalence of lifestyle diseases is projected to fuel market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Vital Organs Support Systems and Medical Bionics Market Research Report
By Type
Hospitals, Ambulatory Surgical Centers, Others
By Application
Vital Organs Support Systems, Medical Bionics
By Companies
Abiomed, Inc., Abbott Laboratories, Asahi Kasei Corporation, Baxter International Inc, Boston Scientific Corporation, Cochlear Ltd., Edwards Lifesciences Corporation, Jarvik Heart, Inc., Medtronic Plc., Össur Americas, Inc., Second Sight Medical Products, Inc., SynCardia Systems LLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
201
Number of Tables & Figures
141
Customization Available
Yes, the report can be customized as per your need.
Global Vital Organs Support Systems and Medical Bionics Market Report Segments:
The global Vital Organs Support Systems and Medical Bionics market is segmented on the basis of:
Types
Hospitals, Ambulatory Surgical Centers, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Vital Organs Support Systems, Medical Bionics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abiomed, Inc.
- Abbott Laboratories
- Asahi Kasei Corporation
- Baxter International Inc
- Boston Scientific Corporation
- Cochlear Ltd.
- Edwards Lifesciences Corporation
- Jarvik Heart, Inc.
- Medtronic Plc.
- Össur Americas, Inc.
- Second Sight Medical Products, Inc.
- SynCardia Systems LLC
Highlights of The Vital Organs Support Systems and Medical Bionics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hospitals
- Ambulatory Surgical Centers
- Others
- By Application:
- Vital Organs Support Systems
- Medical Bionics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vital Organs Support Systems and Medical Bionics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vital Organs Support Systems (VOSS) is a medical technology company that specializes in artificial organs and tissue regeneration. Medical Bionics is a subsidiary of VOSS that manufactures bionic limbs, eyes, and other prosthetic devices.
Some of the major companies in the vital organs support systems and medical bionics market are Abiomed, Inc., Abbott Laboratories, Asahi Kasei Corporation, Baxter International Inc, Boston Scientific Corporation, Cochlear Ltd., Edwards Lifesciences Corporation, Jarvik Heart, Inc., Medtronic Plc., –ssur Americas, Inc., Second Sight Medical Products, Inc., SynCardia Systems LLC.
The vital organs support systems and medical bionics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vital Organs Support Systems and Medical Bionics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Vital Organs Support Systems and Medical Bionics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Vital Organs Support Systems and Medical Bionics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Vital Organs Support Systems and Medical Bionics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Vital Organs Support Systems and Medical Bionics Market Size & Forecast, 2018-2028
4.5.1 Vital Organs Support Systems and Medical Bionics Market Size and Y-o-Y Growth
4.5.2 Vital Organs Support Systems and Medical Bionics Market Absolute $ Opportunity
Chapter 5 Global Vital Organs Support Systems and Medical Bionics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Vital Organs Support Systems and Medical Bionics Market Size Forecast by Type
5.2.1 Hospitals
5.2.2 Ambulatory Surgical Centers
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Vital Organs Support Systems and Medical Bionics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Vital Organs Support Systems and Medical Bionics Market Size Forecast by Applications
6.2.1 Vital Organs Support Systems
6.2.2 Medical Bionics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vital Organs Support Systems and Medical Bionics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vital Organs Support Systems and Medical Bionics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Vital Organs Support Systems and Medical Bionics Analysis and Forecast
9.1 Introduction
9.2 North America Vital Organs Support Systems and Medical Bionics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Vital Organs Support Systems and Medical Bionics Market Size Forecast by Type
9.6.1 Hospitals
9.6.2 Ambulatory Surgical Centers
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Vital Organs Support Systems and Medical Bionics Market Size Forecast by Applications
9.10.1 Vital Organs Support Systems
9.10.2 Medical Bionics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Vital Organs Support Systems and Medical Bionics Analysis and Forecast
10.1 Introduction
10.2 Europe Vital Organs Support Systems and Medical Bionics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Vital Organs Support Systems and Medical Bionics Market Size Forecast by Type
10.6.1 Hospitals
10.6.2 Ambulatory Surgical Centers
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Vital Organs Support Systems and Medical Bionics Market Size Forecast by Applications
10.10.1 Vital Organs Support Systems
10.10.2 Medical Bionics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Vital Organs Support Systems and Medical Bionics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Vital Organs Support Systems and Medical Bionics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Vital Organs Support Systems and Medical Bionics Market Size Forecast by Type
11.6.1 Hospitals
11.6.2 Ambulatory Surgical Centers
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Vital Organs Support Systems and Medical Bionics Market Size Forecast by Applications
11.10.1 Vital Organs Support Systems
11.10.2 Medical Bionics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Vital Organs Support Systems and Medical Bionics Analysis and Forecast
12.1 Introduction
12.2 Latin America Vital Organs Support Systems and Medical Bionics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Vital Organs Support Systems and Medical Bionics Market Size Forecast by Type
12.6.1 Hospitals
12.6.2 Ambulatory Surgical Centers
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Vital Organs Support Systems and Medical Bionics Market Size Forecast by Applications
12.10.1 Vital Organs Support Systems
12.10.2 Medical Bionics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Vital Organs Support Systems and Medical Bionics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Vital Organs Support Systems and Medical Bionics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Vital Organs Support Systems and Medical Bionics Market Size Forecast by Type
13.6.1 Hospitals
13.6.2 Ambulatory Surgical Centers
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Vital Organs Support Systems and Medical Bionics Market Size Forecast by Applications
13.10.1 Vital Organs Support Systems
13.10.2 Medical Bionics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vital Organs Support Systems and Medical Bionics Market: Competitive Dashboard
14.2 Global Vital Organs Support Systems and Medical Bionics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abiomed, Inc.
14.3.2 Abbott Laboratories
14.3.3 Asahi Kasei Corporation
14.3.4 Baxter International Inc
14.3.5 Boston Scientific Corporation
14.3.6 Cochlear Ltd.
14.3.7 Edwards Lifesciences Corporation
14.3.8 Jarvik Heart, Inc.
14.3.9 Medtronic Plc.
14.3.10 Össur Americas, Inc.
14.3.11 Second Sight Medical Products, Inc.
14.3.12 SynCardia Systems LLC
